Hunan Huize Biomedical Technology Co., Ltd.

This study investigated the pharmacokinetic characteristics of a single oral dose of Asartan Potassium Tablets (test preparation, strength: 80 mg) provided by Hunan Huize Biopharmaceutical Technology Co., Ltd. or Asartan Potassium Tablets (reference preparation, trade name: Edabi, strength: 80 mg) certified by Takeda Pharma A/S in healthy subjects under fasting and postprandial conditions, evaluated the bioequivalence and safety of the two preparations, and provided a basis for the registration application of the test preparation.

To study the pharmacokinetic characteristics of a single oral administration of metformin empagliflozin tablets (test preparation, specification: each tablet contains 500 mg of metformin hydrochloride and 5 mg of empagliflozin) provided by Hunan Huize Biotechnology Co., Ltd. in healthy subjects under fasting and postprandial conditions and a single oral administration of metformin empagliflozin tablets (reference preparation, trade name: Synjardy, specification: each tablet contains 500 mg of metformin hydrochloride and 5 mg of empagliflozin) certified by Boehringer Ingelheim Pharmaceuticals Inc. under the same conditions, evaluate the bioequivalence and safety of the two preparations, and provide a basis for the registration application of the test preparation.

This study investigated the pharmacokinetic characteristics of a single oral dose of the test preparation Mesalazine Enteric-coated Tablets (specification: 0.5 g) provided by Hunan Huize Biopharmaceutical Technology Co., Ltd. in healthy subjects under fasting and postprandial conditions, compared with a single oral dose of the reference preparation Mesalazine Enteric-coated Tablets (trade name: Salofalk, specification: 0.5 g) produced by Losan Pharma GmbH (certified by Dr. Falk Pharma GmbH) under the same conditions, to evaluate the bioequivalence and safety of the two preparations, and to provide a basis for the registration application of the test preparation.